These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19082252)

  • 1. [Research to support pharmaceutical policies].
    Wirtz VJ; Reich MR; Hernández-Avila M
    Salud Publica Mex; 2008; 50 Suppl 4():S427-8. PubMed ID: 19082252
    [No Abstract]   [Full Text] [Related]  

  • 2. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
    Burci GL; Gostin LO
    JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485
    [No Abstract]   [Full Text] [Related]  

  • 3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmaceutical policies in Mexico: 20 years is nothing].
    Gasman N
    Salud Publica Mex; 2008; 50 Suppl 4():S423-6. PubMed ID: 19082251
    [No Abstract]   [Full Text] [Related]  

  • 5. From the World Health Organization. Essential medicines: 25 years of better health.
    JAMA; 2002 Dec; 288(24):3102. PubMed ID: 12495381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Douste-Blazy P
    Bull Acad Natl Med; 2014 Nov; 198(8):1483-6. PubMed ID: 27125032
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicines in Mexico, 1990-2004: systematic review of research on access and use.
    Wirtz VJ; Reich MR; Leyva Flores R; Dreser A
    Salud Publica Mex; 2008; 50 Suppl 4():S470-9. PubMed ID: 19082258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?
    MacKay P
    N Z Med J; 2005 May; 118(1214):U1433. PubMed ID: 15886729
    [No Abstract]   [Full Text] [Related]  

  • 9. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
    Moïse P; Docteur E
    Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
    [No Abstract]   [Full Text] [Related]  

  • 10. How the MDGs gave up on measuring access to medicines.
    Gotham D; Onarheim KH; Barber MJ
    Lancet Glob Health; 2016 May; 4(5):e296-7. PubMed ID: 27102189
    [No Abstract]   [Full Text] [Related]  

  • 11. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patents and availability of essential drugs].
    Carné X
    Med Clin (Barc); 2007 Nov; 129(16):617-8. PubMed ID: 18001674
    [No Abstract]   [Full Text] [Related]  

  • 13. Global "hold-em".
    Cassidy BS
    Geriatr Nurs; 2006; 27(1):21-3. PubMed ID: 16483897
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic and policy implications of reimportation: a Canadian perspective.
    Ward C
    Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimportation of pharmaceuticals: economic and policy implications. Proceedings from an internet presentation, October 29-31, 2003.
    Manag Care; 2004 Mar; 13(3 Suppl):1-44. PubMed ID: 15137376
    [No Abstract]   [Full Text] [Related]  

  • 16. A landmark report on improving medicines for children.
    't Jong GW; Klassen TP; MacLeod SM
    JAMA Pediatr; 2015 Mar; 169(3):204-5. PubMed ID: 25561323
    [No Abstract]   [Full Text] [Related]  

  • 17. Powerful Ideas for Global Access to Medicines.
    Moon S
    N Engl J Med; 2017 Feb; 376(6):505-507. PubMed ID: 28099819
    [No Abstract]   [Full Text] [Related]  

  • 18. Making right to health a reality in India.
    Kumar R
    Indian J Public Health; 2007; 51(3):142-4. PubMed ID: 18229437
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving access to NCD medicines through collaboration.
    Chan K; Mandeville KL
    Lancet; 2016 Apr; 387(10029):1704-5. PubMed ID: 27116264
    [No Abstract]   [Full Text] [Related]  

  • 20. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
    Baker BK
    PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.